| Ishita Drugs & Industries Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524400 |
NSE Symbol : - |
P/E(TTM) : 30.81 |
|
ISIN Demat : INE806D01016 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.36 |
|
Book Value(₹) : 38.69 |
Market Cap(₹Cr) : 21.74 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 3.15 | 3.06 | 3.14 | 3.07 | 5.40 | 4.56 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 3.15 | 3.06 | 3.14 | 3.07 | 5.40 | 4.56 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.04 | 0.22 | 0.10 | 0.07 | 0.09 | 0.16 |
| Total Income | 3.18 | 3.27 | 3.23 | 3.14 | 5.49 | 4.72 |
| Total Expenditure | 2.83 | 2.96 | 3.00 | 2.88 | 5.05 | 4.27 |
| PBIDT | 0.35 | 0.31 | 0.24 | 0.25 | 0.44 | 0.45 |
| Interest | 0.00 | 0.02 | 0.02 | 0.00 | 0.02 | 0.04 |
| PBDT | 0.35 | 0.30 | 0.22 | 0.25 | 0.41 | 0.41 |
| Depreciation | 0.05 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 |
| Tax | 0.07 | 0.10 | 0.04 | 0.08 | 0.09 | 0.10 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Reported Profit After Tax | 0.23 | 0.18 | 0.16 | 0.14 | 0.30 | 0.29 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.23 | 0.18 | 0.16 | 0.14 | 0.30 | 0.29 |
| EPS (Unit Curr.) | 0.77 | 0.59 | 0.52 | 0.48 | 1.01 | 0.96 |
| EPS (Adj) (Unit Curr.) | 0.77 | 0.59 | 0.52 | 0.48 | 1.01 | 0.96 |
| Calculated EPS (Unit Curr.) | 0.77 | 0.59 | 0.52 | 0.48 | 1.01 | 0.96 |
| Calculated EPS (Adj) (Unit Curr.) | 0.77 | 0.59 | 0.52 | 0.48 | 1.01 | 0.96 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.08 | 2.37 | 2.08 | 1.92 | 4.04 | 3.85 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.08 | 2.37 | 2.08 | 1.92 | 4.04 | 3.85 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 11.11 | 10.13 | 7.64 | 8.14 | 8.15 | 9.87 |
| PBDTM(%) | 11.11 | 9.80 | 7.01 | 8.14 | 7.59 | 8.99 |
| PATM(%) | 7.30 | 5.88 | 5.10 | 4.56 | 5.56 | 6.36 |
